Duration
Metabolising medication and pharmacokinetic limits : 20h Th
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : 15h Th
Information and adverse drug events monitoring : 10h Th
Number of credits
Advanced Master in Industrial Pharmacy | 5 crédits |
Lecturer
Metabolising medication and pharmacokinetic limits : François-Xavier Mathy
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : Régis Radermecker
Information and adverse drug events monitoring : Raphaël Denooz
Coordinator
Language(s) of instruction
French language
Organisation and examination
All year long, with partial in January
Schedule
Units courses prerequisite and corequisite
Prerequisite or corequisite units are presented within each program
Learning unit contents
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies)
Methodology of clinical trials
Information and adverse drug events monitoring
This course is dedicated to some notions of Information and Publicity in the field of therapeutic drugs. Pharmacovigilancy aspects are also approached. (Definition and imputability criteria of adverse drugs effects, CBPH operating, ...)
Learning outcomes of the learning unit
Information and adverse drug events monitoring
Table of contents:
1. Pharmacovigilancy: Evaluation of the therapeutic risk
2. Pharmacovigilancy in Belgium and in Europe
3. Information and Publicity
4. Excercices
Prerequisite knowledge and skills
Information and adverse drug events monitoring
Toxicology course of the second cycle
Planned learning activities and teaching methods
Information and adverse drug events monitoring
Pointless
Mode of delivery (face to face, distance learning, hybrid learning)
Information and adverse drug events monitoring
3 courses of 3 or 4 hours
Face to face ou distancial
Recommended or required readings
Information and adverse drug events monitoring
PowerPoint slides
Information and adverse drug events monitoring
Written evalation in january
Work placement(s)
Organisational remarks and main changes to the course
Contacts
Information and adverse drug events monitoring
Pr Raphaël DENOOZ
Clinical and Forensic Toxicological laboratory
CHU B35
Sart-Tilman, B4000 Liège
Tél.04/3237683
Fax 04/3238889
e-mail : Raphael.Denooz@chuliege.be